Doctoral Supervisor, FDA Postdoctoral Fellow, Deputy Director of the Department of Pharmacy at the Third XiangYa Hospital, Central South University.

High-level Talent in Health and Medical Sciences of Hunan Province. Inspector at CFDI. Core Board Member of Quantitative Pharmacology Professional  Committee, Chinese Pharmacological Society. Member of Youth Committee for Therapeutic Drug Monitoring of the Chinese Pharmacological Society, Hunan Provincial Pharmaceutical Association, Hunan Provincial Pharmacological Society. Editorial Board Youth Member of  "Chinese Journal of Clinical Pharmacology" and "Chinese Journal of Clinical Pharmacology and Therapeutics."

Achievements: Principal Investigator for leading more than 10 research projects, including the "Major New Drug Development" sub-project of the 13th Five-Year Plan,  National Natural Science Foundation projects (2 grants), and provincial natural foundation projects. Published more than 30 SCI papers as senior author, associate editor-in-chief for 3 books, and obtained 2 granted patents. Awarded the second prize for Scientific and Technological Progress in Hunan Province once and the first prize for Medical Science and Technology in Hunan Province. As a core member, contributed to development of the first domestic Clinical Pharmacology Modeling and Statistical Cloud Platform (CPhaMAS 1.0).

Research Interests: Therapeutic drug monitoring, model-guided new drug development, and precision medicine.

博士生导师，FDA定量药理博士后，中南大学湘雅三医院药学部副主任。
湖南省卫生健康高层次人才—学科带头人，国家药监局审核查验中心检查员，中国药理学会定量药理专委会常务理事，中国药理学会治疗药物监测青委会委员，湖南省药学会理事，湖南省药理学会理事，《中国临床药理学杂志》、 《中国临床药理学与治疗学》青年编委。
科研成果：主持十三五“重大新药创制”子课题、国家自然科学基金（2项）、省自然基金等10余项课题。以第一或通讯发表SCI论文30余篇，副主编著作3部，授权专利2项。湖南省科学技术进步二等奖1次，湖南省医学科技一等奖1次。作为核心成员开发国内首个临床药理建模与统计云平台（CPhaMAS 1.0）
研究方向：治疗药物监测、模型引导的新药研发和精准用药